Association between Catechol-O-methyltransferase gene variant and bipolar disorder

International Journal of Human Genetics

Volumn 11, Issue 1, 2011, Pages 55-58

  Kutumbarao, N H V ^a   Das, Arundhuti ^a   Lakshmi, V ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Bipolar Disorder; Catechol O Methyltransferase (COMT) Gene Variants; Disease Association

Indexed keywords

CATECHOL METHYLTRANSFERASE; TYPE III SITE SPECIFIC DEOXYRIBONUCLEASE;

AMINO ACID SUBSTITUTION; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79954987857     PISSN: 09723757     EISSN: None     Source Type: Journal    
DOI: 10.1080/09723757.2011.11886124     Document Type: Article

References (24)

1. Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J et al. 2007. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord, 9(4): 370-376.
2. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM et al. 2001. Effect of COMT val (108/158) met genotype on frontal lobe function and risk for schizophrenia. Proc Nat Acad Sci, 98: 6917-6922.
3. Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL et al. 2005. COMT genetic variation confers risk for psychotic and affective disorders: A case control study. Behavioral and Brain Functions, 1: 19.
4. Goghari VM, Sponheim SR 2008. Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophr Res, 103(1-3): 186-191.
5. Goodwin FK, Jamison KR 2007. Manic-depressive Illness: Bipolar Disorders and Recurrent Depression. New York: Oxford University Press.
6. Gupta M, Pallav B, Grover S,Kaur H, Baghel R et al. 2009. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Pharmacogenomics, 10(3): 385-397.
7. Gutiérrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ et al. 1997. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry, 154: 1.
8. Kato T 2007. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosc, 61: 3-19.
9. Kirov G, Murphy KC, Arranz MJ, Jones I, McCandles F et al. 1998. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Molecular Psychiatry, 3(4): 342-45.
10. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS et al. 1996. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardiofacial syndrome. Am J Med Genet, 67: 468-472.
11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL,Weinshilboum RM 1996. Human catechol-Omethyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6: 243-250.
12. Lahiri DK, Nurnberger JI 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nuc Acids Res, 19: 5444.
13. Li T, Vallada H, Curtis D, Arranz M, Xu K et al. 1997. Catechol-O-methyltransferase Val158Met polymorphism: Frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics, 7(5): 349-353.
14. Malhotra AK, Kestle L J, Mazzanti C, Bates JA, Goldberg T, Goldman D 2002. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry, 159: 652-654.
15. Männistö PT, Kaakkola S 1999. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacological Reviews, 51(4): 593-628.
16. McIntosh AM Moorhead TMJ, McKirdy J, Hall J, Sussmann JED et al. 2009.Prefrontal gyral foldings and its cognitive correlates in bipolar disorder and schizophrenia. Acta Psychiatr Scand, 119(3): 192-198.
17. Mick E, Wozniak J, Wilens TE, Biederman J, Faraone SV et al. 2009. Family-based association study of the BDNF, COMT and serotonin transporter genes and DSM-IV bipolar-I disorder in children. BMC Psychiatry, 9: 2.
18. Rosack J 2003. Dopamine pathway may link schizophrenia, bipolar disorder. Psychiatric News, 38(3): 21.
19. Shifman S, Bronstein M, Sternfeld M, Pisanté A, Weizman A et al. 2004. COMT: A common susceptibility gene in bipolar disorder and schizophrenia. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 128B: 61-64.
20. Smoller JW, Finn CT, 2003. Family, twin, and adoption bipolar disorder. Am J Med Genet C Semin Med Genet, 123: 48-58.
21. Syvanen A, Tilgmann C, Rinne J, Ulmanen I 1997. Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics, 7: 65-71.
22. 108/158 Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. The Pharmacogenomics Journal, 5: 49-53.
23. Verma R, Kubendran S, Das SK, Jain S, Brahmachari SK 2005. SYNGR1 is associated with schizophrenia and bipolar disorder in Southern India. J Hum Genet, 50(12):635-640.
24. Verma R, Mukerji M, Grover D, B-Rao C, Das SK et al. 2005. MLC1 gene is associated with schizophrenia and bipolar disorder in Southern India. Biol Psychiatry, 58(1): 16-22.